Uncategorized

Jim Rechtin, president and CEO of physician staffing firm Envision Healthcare, will take the reins as chief executive of the payer in the latter half of 2024.

Executives from the three medical device firms said they expect more deal-making in the long term, but face tough discussions about valuations with targets.

The takeover will give Haemonetics devices that complement its vascular closure products, analysts said.

As startups look for exits or are forced to consider a sale due to a lack of new capital in the next two years, companies have the opportunity to build their value propositions at reasonable prices, investors said at HLTH.

Super apps — so-called “everything apps” that combine multiple services in one platform — haven’t taken off in the U.S., but CVS is angling to change that.

In an interview on the center’s launch, the California-based system’s chief innovation officer also said that venture firm General Catalyst, which announced plans to buy a health system this week for product testing, will face “real trial and error.”

Wentworth, who will become Walgreens CEO effective Oct. 23, is the former CEO of Express Scripts, the pharmacy benefit manager acquired by Cigna in 2018.

CNS Pharmaceuticals, Inc. today announced it has achieved enrollment of 229 of the expected 243 patients in the ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent GBM, an aggressive and incurable form of brain cancer.

  ¿Quieres iniciar una Agencia de viajes? En esta oportunidad te mostraré un software para agencias de viajes que simplificará todo el trabajo que debes realizar y te ayudará a iniciar tu negocio en pocos días. ¡Solo tendrás que preocuparte por …

Gritgen Therapeutics Co., Ltd., a biotechnology company focused on discovering and developing innovative gene therapy products, announces the successful validation and official launching of operations at its commercial GMP facility located in Suzhou Industrial Park.